February 2026 UPMC for You and UPMC Community HealthChoices formulary update
Feb. 2026Pharmacy Updates
Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
To avoid denials at the pharmacy, prescribers are encouraged to begin transitioning current Pulmicort Flexhaler patients to covered alternatives as soon as possible.
Preferred/Covered PDL alternatives for Pulmicort Flexhaler include the following*:
- Arnuity Ellipta
- Asmanex HFA
- Asmanex Twisthaler
- Budesonide 0.25 mg/2 mL and 0.5 mg/2 mL Respules
- Qvar Redihaler
- Fluticasone Propionate HFA for patients < 19 years old
*The DHS PDL is subject to review and may be revised periodically.
Recent Announcements
Voluntary nationwide recall: Cetirizine (Unique – July)
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.Jul. 2026Pharmacy Updates
August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates
Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.Jul. 2026Pharmacy Updates
Give feedback on your experience with UPMC Health Plan
You may be invited to participate in a 2026 Press Ganey provider satisfaction survey, which will begin next month. This survey will be given to a random sampling of in-network primary care providers.Jul. 2026Important Notices